Multivariable analysis with adjustment to age and gender revealed that lower baseline Hgb was the only significant predictor of response to IVIS treatment ( P ≤ .0001), while patients who received 1 course versus 2 or more courses ( P = .07) and those who received IVIS while inpatient versus outpatient or both ( P = .06) had results approaching significance.
← all excerpts
Safety and Efficacy of Intravenous Iron Sucrose for Iron-Deficiency Anemia in Children and Adolescents With Inflammatory Bowel Disease.
1
—
—